1. Home
  2. BDSX vs CPSS Comparison

BDSX vs CPSS Comparison

Compare BDSX & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • CPSS
  • Stock Information
  • Founded
  • BDSX 2005
  • CPSS 1991
  • Country
  • BDSX United States
  • CPSS United States
  • Employees
  • BDSX N/A
  • CPSS N/A
  • Industry
  • BDSX Precision Instruments
  • CPSS Finance: Consumer Services
  • Sector
  • BDSX Health Care
  • CPSS Finance
  • Exchange
  • BDSX Nasdaq
  • CPSS Nasdaq
  • Market Cap
  • BDSX 194.9M
  • CPSS 233.1M
  • IPO Year
  • BDSX 2020
  • CPSS 1992
  • Fundamental
  • Price
  • BDSX $1.51
  • CPSS $10.66
  • Analyst Decision
  • BDSX Strong Buy
  • CPSS
  • Analyst Count
  • BDSX 4
  • CPSS 0
  • Target Price
  • BDSX $3.08
  • CPSS N/A
  • AVG Volume (30 Days)
  • BDSX 332.5K
  • CPSS 29.0K
  • Earning Date
  • BDSX 11-01-2024
  • CPSS 10-31-2024
  • Dividend Yield
  • BDSX N/A
  • CPSS N/A
  • EPS Growth
  • BDSX N/A
  • CPSS N/A
  • EPS
  • BDSX N/A
  • CPSS 0.87
  • Revenue
  • BDSX $65,562,000.00
  • CPSS $184,246,000.00
  • Revenue This Year
  • BDSX $46.97
  • CPSS N/A
  • Revenue Next Year
  • BDSX $30.43
  • CPSS $17.21
  • P/E Ratio
  • BDSX N/A
  • CPSS $12.04
  • Revenue Growth
  • BDSX 48.92
  • CPSS N/A
  • 52 Week Low
  • BDSX $1.11
  • CPSS $7.03
  • 52 Week High
  • BDSX $2.21
  • CPSS $12.04
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 48.94
  • CPSS 57.97
  • Support Level
  • BDSX $1.24
  • CPSS $10.54
  • Resistance Level
  • BDSX $1.43
  • CPSS $11.38
  • Average True Range (ATR)
  • BDSX 0.10
  • CPSS 0.37
  • MACD
  • BDSX 0.01
  • CPSS -0.01
  • Stochastic Oscillator
  • BDSX 64.44
  • CPSS 60.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S.-based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent, by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: